Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2014) 35 P1136 | DOI: 10.1530/endoabs.35.P1136

ECE2014 Poster Presentations Thyroid Cancer (70 abstracts)

Prevalence and risk of malignancy of thyroid incidentalomas discovered by 18F-fluorodeoxyglucose positron emission tomography

Tiago Nunes da Silva , Henrique Vara Luiz , Bernardo Dias Pereira , Ana Catarina Matos , Isabel Manita , Susana Carmona , Ana Isabel Santos & Jorge Portugal


Hospital Garcia de Orta, Almada, Portugal.


The use of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG–PET) has increased the detection of thyroid incidentalomas (TI). These are associated with a risk of malignancy between 25 and 50%. Some studies show an association between SUVmax uptake and malignancy.

The objective of this study was to determine the prevalence of malignancy on 18F-FDG–PET positive thyroid nodules and to evaluate the relationship between SUVmax uptake and malignancy in a population of patients followed in a central hospital.

We evaluated retrospectively all 18F-FDG–PET exams performed between 2008 and 2013. The inclusion criterion was focal thyroid uptake in patients studied for non-thyroid purposes.

From the 1810 18F-FDG–PET exams (1384 patients), 3.2% (43) fulfilled the inclusion criteria, 60.5% were females (28), mean age was 68 years. Thyroid ultrasound was done in 39.5% (17) with an average nodule size of 20.5 mm. FNAC was performed in 37.2% (16) with 50% (8) benign, 31% (5) non-diagnostic, 6.5% (1) suspicious for papillary carcinoma and 12.5% (2) papillary carcinoma.

Surgery was performed in the latter two categories, with a histological classification of papillary carcinoma in all three procedures (one with distant metastasis). The median SUVmax was five for the benign cases and 7.95 for the malignant ones (P=0.38).

Focal 18F-FDG–PET thyroid uptake had a prevalence of 3.2%. The prevalence of malignancy was 19% on 18F-FDG–PET positive exams. Only 37.2% were evaluated by FNAC. Two possible explanations are the end of life status of these patients but also the lack of knowledge, on non-endocrine services, regarding the risk of malignancy of TI patients. A trend towards a higher risk of malignancy with higher SUVmax was found although it was not statistically significant. The limitations of the current work reflect an undervaluation of patients at risk and the rather high number of non-diagnostic FNAC.

Article tools

My recent searches

No recent searches.